Mount Sinai St. Luke’s Morningside CRS

Site Details


390 West 114th Street

3rd Floor

New York, NY. 10025

Get Directions



CRS Coordinator

Janet Forcht


CRS Leader

Alexandra Abrams-Downey


Site Trials

HIV comorbidities and complications

Closed to accrual

A5332: REPRIEVE Trial

In this study, people between the ages of 40 and 75 with HIV will be randomized (like flipping a coin) to take the pill pitavastatin OR a placebo (non-active pill) to see if pitavastatin can help prevent heart disease and death in people who are taking HIV medication. You will not know if you are taking pitavastatin or placebo. The REPRIEVE trial will enroll about 7500 people from several countries.